For patients, every encounter is a test not just of the healthcare system, but of whether they are believed and respected.

NYU researchers partnered with Nigerian singer Adekunle Gold to launch an organization that uses music to reduce stigma and ...

After losing two sisters to sickle cell disease, Adesayo Talabi speaks to the Mirror how she uses grief to break the silence, and push for more Black blood donors across the UK ...

Life expectancy has soared and interest in the disease is growing, but breakthrough gene therapies are extraordinarily ...

Patients with sickle cell disease and beta-thalassemia treated with exagamglogene autotemcel reported substantial and ...

Novo Nordisk (($NVO)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a global Phase 3 study ...

The intervention being tested is Osivelotor, a drug designed to treat sickle cell disease. The study also involves the use of Famotidine, a medication that reduces stomach acid, to assess its impact ...

Vertex Pharmaceuticals Inc. (($VRTX)) announced an update on their ongoing clinical study. Vertex Pharmaceuticals Inc. is conducting a Phase 3 ...

For pregnant individuals with sickle cell disease (SCD), low placental growth factor (PlGF) predicts early-onset preeclampsia.

A one-time gene-editing therapy, exagamglogene autotemcel (exa-cel), has demonstrated sustained and clinically meaningful ...

In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring ...

Placental growth factor shows 100% accuracy for early preeclampsia detection in sickle cell disease, new research indicates.